Breaking News Instant updates and real-time market news.

ABT

Abbott

09:41
10/19/16
10/19
09:41
10/19/16
09:41

Abbott CEO says pediatric business in China only about 3% of company sales

  • 19

    Oct

  • 21

    Oct

  • 06

    Nov

ABT Abbott

09/29/16
COWN
09/29/16
NO CHANGE
COWN
Outperform
Cowen says views on Dexcom, Insulet not changed by competitor launches
Cowen analyst Doug Schenkel noted that Abbott (ABT) announced yesterday it had received FDA approval for the professional version of its FreeStyle Libre glucose monitoring product and filed the consumer version of Libre, while Medtronic (MDT) also announced FDA approval of its 670G Hybrid Closed Loop system. Schenkel said Abbott's consumer Libre filing comes a few months ahead of his expectations but that Medtronic's timing was in-line with expectations. The analyst said the competitor announcements, which had been expected, do not change his views on DexCom (DXCM), Insulet (PODD), or Tandem Diabetes (TNDM) and he keeps Outperform ratings on all three of those stocks.
09/29/16
ADAM
09/29/16
NO CHANGE
Target $53
ADAM
Buy
Alere risk-reward looks 'quite good' as deal debate nears end, says Canaccord
Canaccord analyst Mark Massaro said he is optimistic that a conclusion of Abbott (ABT) and Alere's (ALR) merger fight is "not far off" and he still believes Abbott will ultimately acquire Alere, though he also thinks the merger may be decided by a judge. Massaro puts a 65% probability on the likelihood the deal closes at the $56 deal price, a 30% chance that Abbott buys Alere at a lower price nearer to $50 per share, and only a 5% chance the deal breaks, making the risk-reward ratio in Alere shares at current levels "quite good," he tells investors. He trimmed his price target on Alere to $53 from $56 an keeps a Buy rating on the stock.
09/29/16
BARD
09/29/16
NO CHANGE
BARD
Dexcom, Insulet could be weighed down by competitive concerns, says Baird
Baird analyst Jeff Johnson said that while the FDA approvals announced yesterday for Abbott's (ABT) FreeStyle Libre Pro and Medtronic's (MDT) 670G were largely anticipated, he believes that both approvals came sooner than most expected, as did news that Abbott also recently filed for FDA approval of its consumer Libre system. The approvals could "change the narrative" in diabetes and could weigh on others in the sector in the near-term, most notably Dexcom (DXCM) and Insulet (PODD), Johnson tells investors. He keeps Neutral ratings on both and maintains an Overweight rating on Tandem Diabetes (TNDM), citing valuation for the difference.
10/11/16
COWN
10/11/16
NO CHANGE
Target $85
COWN
Outperform
Cowen says St. Jude advisory common for the industry
While Dear Doctor letters are never a positive, St. Jude Medical's (STJ) medical device advisory relating to a low rate of premature battery depletion in the high voltage portfolio is common in the Cardiac Rhythm Management industry, Cowen analyst Joshua Jennings tells investors in a research note. The analyst sees limited risk to St. Jude's franchise and still expects the takeover by Abbott Laboratories' (ABT) to close by the end of the year. Jennings keeps an Outperform rating on St. Jude shares with an $85 price target. The stock is down 1% to $80.19 in pre-market trading.

TODAY'S FREE FLY STORIES

KBR

KBR

$15.48

-0.02 (-0.13%)

06:10
04/28/17
04/28
06:10
04/28/17
06:10
Earnings
KBR backs FY17 adj. EPS view of $1.10-$1.40, sees results above midpoint »

Consensus $1.27. The…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

ATHN

athenahealth

$121.45

1.6 (1.34%)

06:09
04/28/17
04/28
06:09
04/28/17
06:09
Recommendations
athenahealth analyst commentary  »

Piper expects…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

  • 17

    May

HST

Host Hotels

$19.24

-0.03 (-0.16%)

06:08
04/28/17
04/28
06:08
04/28/17
06:08
Hot Stocks
Breaking Hot Stocks news story on Host Hotels »

Host Hotels sees FY17 …

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

WDC

Western Digital

$85.71

1.1 (1.30%)

06:08
04/28/17
04/28
06:08
04/28/17
06:08
Technical Analysis
Western Digital trades sharply higher after earnings beat »

In the pre-market the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EXPE

Expedia

$136.20

0.45 (0.33%)

06:06
04/28/17
04/28
06:06
04/28/17
06:06
Downgrade
Expedia rating change  »

Expedia downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    May

  • 16

    May

SBUX

Starbucks

$61.30

-0.26 (-0.42%)

06:06
04/28/17
04/28
06:06
04/28/17
06:06
Recommendations
Starbucks analyst commentary  »

Piper still a buyer of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

CPN

Calpine

$9.59

-0.33 (-3.33%)

06:06
04/28/17
04/28
06:06
04/28/17
06:06
Hot Stocks
Calpine sees FY17 adjusted EBITDA $1.8B-$1.95B »

Sees FY17 growth CapEx…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MET

MetLife

$52.14

0.25 (0.48%)

06:06
04/28/17
04/28
06:06
04/28/17
06:06
Hot Stocks
MetLife's Kandarian says to invest $1B in efficiency enhancements for 2016-2019 »

MetLife CEO Steve…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    May

  • 13

    Jun

DRAD

Digirad Corp

$5.15

-0.05 (-0.96%)

06:06
04/28/17
04/28
06:06
04/28/17
06:06
Earnings
Digirad Corp sees FY17 adjusted EPS 10c-15c, consensus 26c »

Sees FY17 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

  • 28

    Apr

AGRX

Agile Therapeutics

$3.28

-0.02 (-0.61%)

06:05
04/28/17
04/28
06:05
04/28/17
06:05
Conference/Events
Agile Therapeutics management to meet with William Blair »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

CPN

Calpine

$9.59

-0.33 (-3.33%)

06:05
04/28/17
04/28
06:05
04/28/17
06:05
Earnings
Calpine reports Q1 EPS (16c), consensus (12c) »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KBR

KBR

$15.48

-0.02 (-0.13%)

06:04
04/28/17
04/28
06:04
04/28/17
06:04
Earnings
KBR reports Q1 EPS ex-items 28c, consensus 29c »

Reports Q1 revenue $1.1B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

DRAD

Digirad Corp

$5.15

-0.05 (-0.96%)

06:04
04/28/17
04/28
06:04
04/28/17
06:04
Earnings
Digirad Corp reports Q1 adjusted EPS (1c), consensus 5c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

  • 28

    Apr

HST

Host Hotels

$19.24

-0.03 (-0.16%)

06:03
04/28/17
04/28
06:03
04/28/17
06:03
Earnings
Host Hotels sees FY17 EPS 73c-81c, consensus 67c »

Sees FY17 GAAP revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

GIMO

Gigamon

$36.00

-0.6 (-1.64%)

06:03
04/28/17
04/28
06:03
04/28/17
06:03
Downgrade
Gigamon rating change  »

Gigamon downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Jun

AVT

Avnet

$40.86

-3.72 (-8.34%)

06:02
04/28/17
04/28
06:02
04/28/17
06:02
Downgrade
Avnet rating change  »

Avnet downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MSFT

Microsoft

$68.27

0.44 (0.65%)

06:02
04/28/17
04/28
06:02
04/28/17
06:02
Recommendations
Microsoft analyst commentary  »

Piper an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

  • 09

    May

ZEUS

Olympic Steel

$19.23

-0.64 (-3.22%)

06:02
04/28/17
04/28
06:02
04/28/17
06:02
Earnings
Olympic Steel reports Q1 EPS 68c, consensus 40c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

  • 28

    Apr

HST

Host Hotels

$19.24

-0.03 (-0.16%)

06:01
04/28/17
04/28
06:01
04/28/17
06:01
Earnings
Host Hotels reports Q1 EPS 21c, consensus 15c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

CVNA

Carvana

06:01
04/28/17
04/28
06:01
04/28/17
06:01
Syndicate
Carvana 15M share IPO priced at $15.00 »

The deal range was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

ZYME

Zymeworks

06:00
04/28/17
04/28
06:00
04/28/17
06:00
Syndicate
Zymeworks 4.5M share IPO priced at $13.00 »

The deal range was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

POR

Portland General Electric

$46.38

0.13 (0.28%)

06:00
04/28/17
04/28
06:00
04/28/17
06:00
Earnings
Breaking Earnings news story on Portland General Electric »

Portland General Electric…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

FB

Facebook

$147.70

1.14 (0.78%)

06:00
04/28/17
04/28
06:00
04/28/17
06:00
Hot Stocks
Facebook makes Messenger Lite available in 150 additional countries »

Facebook's head of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

  • 08

    May

  • 16

    May

POR

Portland General Electric

$46.38

0.13 (0.28%)

05:59
04/28/17
04/28
05:59
04/28/17
05:59
Earnings
Portland General Electric reports Q1 EPS 82c, consensus 82c »

Reports Q1 revenue $530M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

GOOG

Alphabet

$874.25

2.52 (0.29%)

, GOOGL

Alphabet Class A

$891.44

2.3 (0.26%)

05:58
04/28/17
04/28
05:58
04/28/17
05:58
Recommendations
Alphabet, Alphabet Class A analyst commentary  »

Alphabet price target…

GOOG

Alphabet

$874.25

2.52 (0.29%)

GOOGL

Alphabet Class A

$891.44

2.3 (0.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

  • 16

    May

  • 22

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.